Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adi Zheng

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Current Opinion in Lipidology|September 4, 2020
The interplay between serum amyloid A and HDLsAdi Zheng, Christian Widmann
Cells|November 27, 2021
Integrative Analyses Reveal <i>Tstd1</i> as a Potential Modulator of HDL Cholesterol and Mitochondrial Function in MiceAdi Zheng, Hao Li, Zhihui Feng, et al.
Oxidative Medicine and Cellular Longevity|January 18, 2020
Autophagy Deficiency Leads to Impaired Antioxidant Defense via p62-FOXO1/3 AxisLin Zhao, Hao Li, Yan Wang, et al.
Cellular Signalling|June 24, 2019
The PI3K/Akt pathway is not a main driver in HDL-mediated cell protectionAdi Zheng, Gilles Dubuis, Carla Susana Mendes Ferreira, et al.
Biochemical and Biophysical Research Communications|May 28, 2018
USP10 regulates the stability of the EMT-transcription factor Slug/SNAI2Amanda Tomie Ouchida, Merve Kacal, Adi Zheng, et al.
The Journal of Nutritional Biochemistry|December 3, 2014
Maternal hydroxytyrosol administration improves neurogenesis and cognitive function in prenatally stressed offspringAdi Zheng, Hao Li, Ke Cao, et al.
Cell Reports|June 15, 2017
PHGDH Defines a Metabolic Subtype in Lung Adenocarcinomas with Poor PrognosisBoxi Zhang, Adi Zheng, Per Hydbring, et al.
Current Cancer Drug Targets|November 27, 2013
Anticancer effect of a curcumin derivative B63: ROS production and mitochondrial dysfunctionAdi Zheng, Hao Li, Xun Wang, et al.
Oncotarget|January 7, 2020
CRISPR/Cas9 genome-wide screening identifies KEAP1 as a sorafenib, lenvatinib, and regorafenib sensitivity gene in hepatocellular carcinomaAdi Zheng, Nadja Chevalier, Margot Calderoni, et al.
Biochemical Pharmacology|October 23, 2025
RNA-binding protein GIGYF2 promotes colorectal cancer progression through activation of the METTL3/SERP1/STAT3 axis in an m6A-IGF2BP2-dependent mannerFanglin Niu, Yuanyuan Ren, Yang Li, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Current Opinion in Lipidology|September 4, 2020
The interplay between serum amyloid A and HDLsAdi Zheng, Christian Widmann
Cells|November 27, 2021
Integrative Analyses Reveal <i>Tstd1</i> as a Potential Modulator of HDL Cholesterol and Mitochondrial Function in MiceAdi Zheng, Hao Li, Zhihui Feng, et al.
Oxidative Medicine and Cellular Longevity|January 18, 2020
Autophagy Deficiency Leads to Impaired Antioxidant Defense via p62-FOXO1/3 AxisLin Zhao, Hao Li, Yan Wang, et al.
Cellular Signalling|June 24, 2019
The PI3K/Akt pathway is not a main driver in HDL-mediated cell protectionAdi Zheng, Gilles Dubuis, Carla Susana Mendes Ferreira, et al.
Biochemical and Biophysical Research Communications|May 28, 2018
USP10 regulates the stability of the EMT-transcription factor Slug/SNAI2Amanda Tomie Ouchida, Merve Kacal, Adi Zheng, et al.
The Journal of Nutritional Biochemistry|December 3, 2014
Maternal hydroxytyrosol administration improves neurogenesis and cognitive function in prenatally stressed offspringAdi Zheng, Hao Li, Ke Cao, et al.
Cell Reports|June 15, 2017
PHGDH Defines a Metabolic Subtype in Lung Adenocarcinomas with Poor PrognosisBoxi Zhang, Adi Zheng, Per Hydbring, et al.
Current Cancer Drug Targets|November 27, 2013
Anticancer effect of a curcumin derivative B63: ROS production and mitochondrial dysfunctionAdi Zheng, Hao Li, Xun Wang, et al.
Oncotarget|January 7, 2020
CRISPR/Cas9 genome-wide screening identifies KEAP1 as a sorafenib, lenvatinib, and regorafenib sensitivity gene in hepatocellular carcinomaAdi Zheng, Nadja Chevalier, Margot Calderoni, et al.
Biochemical Pharmacology|October 23, 2025
RNA-binding protein GIGYF2 promotes colorectal cancer progression through activation of the METTL3/SERP1/STAT3 axis in an m6A-IGF2BP2-dependent mannerFanglin Niu, Yuanyuan Ren, Yang Li, et al.
Pageof 2